Rights and permissions
About this article
Cite this article
Sunitinib potentially cost effective for metastatic renal cancer. Inpharma Wkly. 1613, 11 (2007). https://doi.org/10.2165/00128413-200716130-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716130-00015